MAIER PAUL V Insider Trading Activity

Average Profitability
7.11%
Insider Buys Quantity
1
Insider Buys Sum
$30,000.00
Insider Sells Quantity
7
Insider Sells Sum
$3.43M

Insider Activity of MAIER PAUL V

According to the SEC Form 4 filings, MAIER PAUL V, being in a position of

  1. director at Eton Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 50000 shares for $2.95M,
    over all time since 2018-11-15, has bought 5000 shares for $30,000, and sold 50000 shares for $2.95M.

Biography of MAIER PAUL V

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,953,5721100

Comparison of Insiders on Amount of Buys and Sells

2026-08-28SaleEton Pharmaceuticals, Inc.
ETON
director
50,000
0.1804%
$59.07$2.95M-7.61%
2018-11-15PurchaseEton Pharmaceuticals, Inc.
ETON
director
5,000
0.0773%
$6.00$30,000+7.11%
2006-11-20SaleLigand Pharmaceuticals Incorporated
LGND
Sr. V-P, CFO
54,032
0.0692%
$11.42$617,181-18.3%
2006-11-17SaleLigand Pharmaceuticals Incorporated
LGND
Sr. V-P, CFO
126,618
0.1606%
$11.39$1.44M-18.52%
2006-11-16SaleLigand Pharmaceuticals Incorporated
LGND
Sr. V-P, CFO
67,944
0.0866%
$11.35$770,827-17.88%
2004-07-01SaleLigand Pharmaceuticals Incorporated
LGND
Sr. V-P, CFO
8,000
0.0112%
$17.03$136,250-41.58%
2004-06-01SaleLigand Pharmaceuticals Incorporated
LGND
Sr. V-P, CFO
12,000
0.016%
$20.36$244,260-51.4%
2004-05-26SaleLigand Pharmaceuticals Incorporated
LGND
Sr. V-P, CFO
4,000
0.005%
$19.50$78,000-51.62%
2004-05-17SaleLigand Pharmaceuticals Incorporated
LGND
Sr. V-P, CFO
8,000
0.0106%
$17.43$139,440-42.63%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.